Heregulin and retinoids synergistically induce branching morphogenesis of breast cancer cells cultivated in 3D collagen gels

Journal of Cellular Physiology

Volumn 195, Issue 2, 2003, Pages 260-275

  Offterdinger, Martin ^a   Schneider, Sonja M ^a   Grunt, Thomas W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; COLLAGEN GEL; COLLAGEN TYPE 1; INTEGRIN; NEU DIFFERENTIATION FACTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RETINOID X RECEPTOR; RO 257386; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MORPHOGENESIS; ONCOGENE C ERB; PRIORITY JOURNAL;

ANTIGENS, SURFACE; BREAST NEOPLASMS; CADHERINS; CARCINOMA; CELL ADHESION; CELL AGGREGATION; CELL DIFFERENTIATION; CELL SIZE; CELL TRANSFORMATION, NEOPLASTIC; COLLAGEN; DRUG INTERACTIONS; EPITHELIAL CELLS; FEMALE; HUMANS; INTEGRINS; NEUREGULIN-1; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, RETINOIC ACID; RETINOIDS; TUMOR CELLS, CULTURED;

EID: 0037401892     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10237     Document Type: Article

References (59)

1. Adamson ED, Minchiotti G, Salomon DS. 2002. Cripto: A tumor growth factor and more. J Cell Physiol 190:267-278.
2. Aguilar Z, Akita RW, Finn RS, Ramos BL, Pegram MD, Kabbinavar FF, Pietras RJ, Pisacane P, Sliwkowski MX, Slamon DJ. 1999. Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene 18:6050-6062.
3. Altucci L, Gronemeyer H. 2001. The promise of retinoids to fight against cancer. Nat Rev Cancer 1:181-193.
4. Bacus SS, Kiguchi K, Chin D, King CR, Huberman E. 1990. Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER-2/neu antigen. Mol Carcinog 3:350-362.
5. Baeckstrom D, Alford D, Taylor-Papadimitriou J. 2000. Morphogenetic and proliferative responses to heregulin of mammary epithelial cells in vitro are dependent on HER2 and HER3 and differ from the responses to HER2 homodimerisation or hepatocyte growth factor. Int J Oncol 16:1081-1090.
6. Bartek J, Bartkova J, Kyprianou N, Lalani EN, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J. 1991. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of Simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 88:3520-3524.
7. Belkin VM, Kozlova NI, Bychkova VV, Shekhonin BV. 1996. Beta 1 integrin subunit dimerization via disulfide bonds. Biochem Mol Biol Int 40:53-60.
8. Berdichevsky F, Taylor-Papadimitriou J. 1991. Morphological differentiation of hybrids of human mammary epithelial cell lines is dominant and correlates with the pattern of expression of intermediate filaments. Exp Cell Res 194:267-274.
9. Berdichevsky F, Gilbert C, Shearer M, Taylor-Papadimitriou J. 1992. Collagen-induced rapid morphogenesis of human mammary epithelial cells: The role of the alpha 2 beta 1 integrin. J Cell Sci 102:437-446.
10. Berdichevsky F, Alford D, D'Souza B, Taylor-Papadimitriou J. 1994. Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci 107:3557-3568.
11. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SR. 1994. Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31:191-202.
12. Byers S, Pishvaian M, Crockett C, Peer C, Tozeren A, Sporn M, Anzano M, Lechleider R. 1996. Retinoids increase cell-cell adhesion strength, beta-catenin protein stability, and localization to the cell membrane in a breast cancer cell line: A role for serine kinase activity. Endocrinology 137:3265-3273.
13. Chausovsky A, Tsarfaty I, Kam Z, Yarden Y, Geiger B, Bershadsky AD. 1998. Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells. Mol Biol Cell 9:3195-3209.
14. Coleman-Krnacik S, Rosen JM. 1994. Differential temporal and spatial gene expression of fibroblast growth factor family members during mouse mammary gland development. Mol Endocrinol 8:218-229.
15. D'Souza B, Taylor-Papadimitriou J. 1994. Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci USA 91:7202-7206.
16. D'Souza B, Berdichevsky F, Kyprianou N, Taylor-Papadimitriou J. 1993. Collagen-induced morphogenesis and expression of the alpha 2-integrin subunit is inhibited in c-erbB2-transfected human mammary epithelial cells. Oncogene 8:1797-1806.
17. Flicker SH, Schneider SM, Offterdinger M, Dittrich E, Fazeny B, Valenta R, Huber H, Dittrich C, Grunt TW. 1997. Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-alpha in SK-BR-3 breast cancer cells. Cancer Lett 115:63-72.
18. Frixen UH, Nagamine Y. 1993. Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion. Cancer Res 53:3618-3623.
19. Griffiths AB, Burchell J, Gendler S, Lewis A, Blight K, Tilly R, Taylor-Papadimitriou J. 1987. Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells. Int J Cancer 40:319-327.
20. Grunt TW, Huber H. 1994. The family of c-erbB genes: From basic research to clinical oncology. Onkologie 17:346-357.
21. Grunt TW, Dittrich E, Offterdinger M, Schneider SM, Dittrich C, Huber H. 1998. Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth, and cisplatin sensitivity of breast cancer cells. Br J Cancer 78:79-87.
22. Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, Doggett N, Johnson K, Wheelock M, Herman J, et al. 1998. Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 58:1972-1977.
23. Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, Bissell MJ. 1998. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J Cell Biol 140:159-169.
24. Kapron-Bras C, Fitz-Gibbon L, Jeevaratnam P, Wilkins J, Dedhar S. 1993. Stimulation of tyrosine phosphorylation and accumulation of GTP-bound p21ras upon antibody-mediated alpha 2 beta 1 integrin activation in T-lymphoblastic cells. J Biol Chem 268:20701-20704.
25. Keely PJ, Fong AM, Zutter MM, Santoro SA. 1995. Alteration of collagen-dependent adhesion, motility, and morphogenesis by the expression of antisense α2 integrin mRNA in mammary cells. J Cell Sci 108:595-607.
26. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ. 1979. Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15:659-670.
27. Lacroix H, Iglehart JD, Skinner MA, Kraus MH. 1989. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 4:145-151.
28. Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC. 1992. Expression of the ERBB3 gene product in breast cancer. Br J Cancer 66:1116-1121.
29. Maemura M, Akiyama SK, Woods VL, Jr. Dickson RB. 1995. Expression and ligand binding of alpha 2 beta 1 integrin on breast carcinoma cells. Clin Exp Metastasis 13:223-235.
30. Marth C, Bock G, Daxenbichler G. 1985. Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J Natl Cancer Inst 75:871-875.
31. Meiners S, Brinkmann V, Naundorf H, Birchmeier W. 1998. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16:9-20.
32. Moghal N, Neel BG. 1998. Integration of growth factor, extracellular matrix, and retinoid signals during bronchial epithelial cell differentiation. Mol Cell Biol 18:6666-6678.
33. Offterdinger M, Schneider SM, Huber H, Grunt TW. 1998. Retinoids control the expression of c-erbB receptors in breast cancer cells. Biochem Biophys Res Commun 251:907-913.
34. Offterdinger M, Schneider SM, Huber H, Grunt TW. 1999. Expression of c-erbB-4/HER4 is regulated in T47D breast carcinoma cells by retinoids and vitamin D3. Biochem Biophys Res Commun 258:559-564.
35. Offterdinger M, Schöfer C, Weipoltshammer K, Grunt TW. 2002. C-erbB-3: A nuclear protein in mammary epithelial cells. J Cell Biol 157:929-940.
36. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. 1996. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10:2462-2477.
37. Osherov N, Gazit A, Gilon C, Levitzki A. 1993. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J Biol Chem 268:11134-11142.
38. Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM, Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy JA, et al. 1998. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol 16:2659-2671.
39. Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y. 1993. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J 12:961-971.
40. Pellegrini R, Mariotti A, Tagliabue E, Bressan R, Bunone G, Coradini D, Della Valle G, Formelli F, Cleris L, Radice P. 1995. Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide. Cell Growth Differ 6:863-869.
41. Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. 1995. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Oncogene 11:1319-1326.
42. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, Buckley S. 1993. Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366:473-475.
43. Salomon DS, Bianco C, De-Santis M. 1999. Cripto: A novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays 21:61-70.
44. Sasaki M, Nishio M, Tsukada Y, Enami J. 1998. Mammary fibroblast-derived hepatocyte growth factor stimulates growth and morphogenesis of mouse mammary tumor cells in primary culture. Jpn J Cancer Res 89:1134-1143.
45. Schneider SM, Offterdinger M, Huber H, Grunt TW. 1999. Involvement of nuclear steroid/thyroid/retinoid receptors and of protein kinases in the regulation of growth and of c-erbB and retinoic acid receptor expression in MCF-7 breast cancer cells. Breast Cancer Res Treat 58:171-181.
46. Schneider SM, Offterdinger M, Huber H, Grunt TW. 2000. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res 60:5479-5487.
47. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. 2001. The interplay of matrix metalloproteinases, morphogens, and growth factors is necessary for branching of mammary epithelial cells. Development 128:3117-3131.
48. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL, III. 1994. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665.
49. Sun H, Santoro SA, Zutter MM. 1998. Downstream events in mammary gland morphogenesis mediated by reexpression of the alpha2beta1 integrin: The role of the alpha6 and beta4 integrin subunits. Cancer Res 58:2224-2233.
50. Tan M, Grijalva R, Yu D. 1999. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase. Cancer Res 59:1620-1625.
51. Wang X-Q, Frazier WA. 1998. The thrombospondin receptor CD47 (IAP) modulates and associates with α2β1 integrin in vascular smooth muscle cells. Mol Biol Cell 9:865-874.
52. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ. 1998. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology. Proc Natl Acad Sci USA 95:14821-14826.
53. Wang Z, Symons JM, Goldstein SL, McDonald A, Miner JH, Kreidberg JA. 1999. (Alpha)3(beta)1 integrin regulates epithelial cytoskeletal organization. J Cell Sci 112:2925-2935.
54. Wayner EA, Carter WG. 1987. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique α and common β subunits. J Cell Biol 105:1873-1884.
55. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. 1997. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231-245.
56. Wiesen JF, Young P, Werb Z, Cunha GR. 1999. Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126:335-344.
57. Wilkins JA, Li A, Ni H, Stupack DG, Shen C. 1996. Control of beta1 integrin function: Localization of stimulatory epitopes. J Biol Chem 271:3046-3051.
58. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W. 1995. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131:215-226.
59. Yant J, Buluwela L, Niranjan B, Gusterson B, Kamalati T. 1998. In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp Cell Res 241:476-481.